Earnings History Data for Kura Oncology, Inc. (KURA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Kura Oncology, Inc.

Kura Oncology, Inc. is a biopharmaceutical company. The company is involved in the discovery and development of therapeutics for the treatment of tumors and blood cancers. Its product pipeline includes small molecule drug candidates which are in different clinical trial consists of Tipifarnib-HRAS, Tipifarnib-PTCL, ERK inhibitor program and Menin MLL inhibitor program. Kura Oncology, Inc. is headquartered in La Jolla, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	AH		KURA	Kura Oncology, Inc.	1,340	-0.63	-0.64	-0.50	Kura Oncology GAAP EPS of -$0.63 in-line [11/7/2024 4:47 PM]	17.64	-0.13 (-0.76%)	17.70	-0.07 (-0.39%)	8.17 - 24.17	536,511	690,000	29,648
Kura Oncology GAAP EPS of -$0.63 in-line [11/7/2024 4:47 PM] Kura Oncology Reports Third Quarter 2024 Financial Results [2024-11-07 04:05PM]
08-08-2024	AH		KURA	Kura Oncology, Inc.	1,460	-0.59	-0.63	-0.53	Kura Oncology GAAP EPS of -$0.59 beats by $0.04 [8/8/2024 4:27 PM]	18.96	-0.16 (-0.84%)	19.12	0.0 (0.00%)	7.41 - 24.17	464,731	780,000	78,010
FDA clears Kura to begin Phase 1 study of ziiftomenib for GIST [8/8/2024 11:11 AM] Kura Oncology GAAP EPS of -$0.59 beats by $0.04 [8/8/2024 4:27 PM]
02-05-2024	AH		KURA	Kura Oncology, Inc.	1,530	-0.59	-0.56	-0.50	Kura Oncology GAAP EPS of -$0.59 misses by $0.03 [5/2/2024 4:09 PM]	20.66	0.07 (0.34%)	18.50	-2.09 (-10.15%)	7.41 - 24.17	472,864	920,000	307
Kura Oncology GAAP EPS of -$0.59 misses by $0.03 [5/2/2024 4:09 PM]
27-02-2024	AH		KURA	Kura Oncology, Inc.	1,500	-0.55	-0.56	-0.49	Kura Oncology GAAP EPS of -$0.55 in-line [2/27/2024 4:04 PM]	21.39	-0.37 (-1.70%)	21.09	-0.67 (-3.08%)	7.41 - 22.92	1,477,409	840,000	357
Kura Oncology GAAP EPS of -$0.55 in-line [2/27/2024 4:04 PM]
02-11-2023	AH		KURA	Kura Oncology, Inc.	627.30	-0.50	-0.56	-0.53	Kura Oncology GAAP EPS of -$0.50 beats by $0.05 [11/2/2023 4:29 PM]	9.00	0.58 (6.89%)	8.42	0.0 (0.00%)	7.41 - 16.37	1,027,656	620,000	11,470
Kura Oncology GAAP EPS of -$0.50 beats by $0.05 [11/2/2023 4:29 PM] Kura Oncology files for $150M common stock offering, mixed securities shelf [11/3/2023 8:02 AM]
03-08-2023	AH		KURA	Kura Oncology, Inc.	707.65	-0.53	-0.57	-0.52	Kura Oncology GAAP EPS of -$0.53 beats by $0.01 [8/3/2023 4:53 PM]	11.00	0.46 (4.36%)	10.54	0.0 (0.00%)	9.49 - 17.49	488,065	510,000	3,275
Kura Oncology GAAP EPS of -$0.53 beats by $0.01 [8/3/2023 4:53 PM]
10-05-2023	AH	After the close (May 10)	KURA	Kura Oncology, Inc.	765.83	-0.50	-0.54	-0.49	Kura Oncology GAAP EPS of -$0.50 beats by $0.04 [5/10/2023 4:34 PM]	12.38	0.93 (8.12%)	11.45	0.0 (0.00%)	9.49 - 19.93	437,965	530,000	13,978
Kura Oncology GAAP EPS of -$0.50 beats by $0.04 [5/10/2023 4:34 PM]
23-02-2023	AH	After the close (Feb 23)	KURA	Kura Oncology, Inc.	838.04	-0.49	-0.58	-0.49	Kura Oncology GAAP EPS of -$0.49 beats by $0.08 [2/23/2023 4:23 PM]	11.70	-0.33 (-2.78%)	12.03	0.0 (0.00%)	10.41 - 19.93	1,465,123	590,000	19,662
Kura Oncology GAAP EPS of -$0.49 beats by $0.08 [2/23/2023 4:23 PM]
03-11-2022	PM	7:20 AM ET (Nov 3)	KURA	Kura Oncology, Inc.	1,070	-0.53	-0.56	-0.50	Kura Oncology GAAP EPS of -$0.53 beats by $0.03 [11/3/2022 7:59 AM]	15.35	-0.24 (-1.57%)	15.70	0.11 (0.71%)	10.41 - 19.93	5,025,533	840,000	3,350
Kura Oncology Q3 2022 Earnings Preview [11/2/2022 12:33 PM] Kura Oncology GAAP EPS of -$0.53 beats by $0.03 [11/3/2022 7:59 AM] Kura Oncology rises on $25M equity investment from Bristol Myers [11/3/2022 8:33 AM] Kura Oncology Reports Third Quarter 2022 Financial Results [Nov-03-22 07:30AM] Kura Oncology Announces Financing Transactions with Bristol Myers Squibb and Hercules Capital, Providing Access to up to $150 Million [Nov-03-22 07:00AM] Kura Oncology to Participate in Two Upcoming Investor Conferences [Nov-02-22 07:30AM] Kura Oncology Announces Four Abstracts Accepted for Presentation at ASH Annual Meeting [Nov-03-22 09:00AM]
03-08-2022	AH	4:05 PM ET (Aug 3)	KURA	Kura Oncology, Inc.	1,040	-0.52	-0.52	-0.51	Kura Oncology GAAP EPS of -$0.52 in-line [8/3/2022 4:34 PM]	15.04	-0.04 (-0.30%)	15.12	0.04 (0.27%)	10.41 - 21.19	2,223,297	850,000	364
Kura Oncology GAAP EPS of -$0.52 in-line [8/3/2022 4:34 PM] Kura Oncology to Participate in Wedbush PacGrow Healthcare Virtual Conference [Aug-02-22 07:30AM] Kura Oncology Reports Second Quarter 2022 Financial Results [Aug-03-22 04:03PM]
04-05-2022	AH	4:00 PM ET (May 4)	KURA	Kura Oncology	956.00	-0.49	-0.52	0.00	Kura Oncology GAAP EPS of -$0.49 beats by $0.03 [5/4/2022 4:28 PM]	13.09	-1.56 (-10.65%)	14.65	0.0 (0.00%)	11.49 - 26.41	439,675	500,000	8,787
Kura Oncology GAAP EPS of -$0.49 beats by $0.03 [5/4/2022 4:28 PM] Kura Oncology Reports First Quarter 2022 Financial Results [May-04-22 04:05PM]
24-02-2022	AH	4:05 PM ET (Feb 24)	KURA	Kura Oncology, Inc.	962.40	-0.49	-0.54	-0.45	Kura Oncology GAAP EPS of -$0.49 beats by $0.05 [2/24/2022 4:26 PM]	15.76	1.17 (8.02%)	14.59	0.0 (0.00%)	11.49 - 32.33	504,197	1,120,000	14,982
Kura Oncology GAAP EPS of -$0.49 beats by $0.05 [2/24/2022 4:26 PM] Kura Oncology Reports Fourth Quarter and Full Year 2021 Financial Results [Feb-24-22 04:03PM]
04-11-2021	AH	4:05 PM ET (Nov 4)	KURA	Kura Oncology, Inc.	1,130	-0.50	-0.54	-0.42	Kura Oncology EPS beats by $0.04 [11/4/2021 4:40 PM]	19.54	1.48 (8.19%)	18.20	0.14 (0.78%)	15.12 - 43.00	856,484	560,000	16,461
Kura Oncology EPS beats by $0.04 [11/4/2021 4:40 PM] Kura Oncology Reports Third Quarter 2021 Financial Results [Nov-04-21 04:05PM] Kura Oncology, inc (KURA) Q3 2021 Earnings Call Transcript [Nov-05-21 01:00PM]
05-08-2021	AH	4:00 PM ET (Aug 5)	KURA	Kura Oncology, Inc.	1,200	-0.51	-0.49	-0.40	Kura Oncology EPS misses by $0.02 [8/5/2021 4:13 PM]	17.82	-0.50 (-2.73%)	18.32	0.0 (0.00%)	17.09 - 43.00	759,357	420,000	3,251
Kura Oncology to Participate in Wedbush PacGrow Healthcare Virtual Conference [Aug-04-21 07:30AM] Kura Oncology Reports Second Quarter 2021 Financial Results [Aug-05-21 04:05PM] Kura Oncology, inc (KURA) Q2 2021 Earnings Call Transcript [Aug-06-21 02:30PM]
06-05-2021	AH	4:05 PM ET (May 6)	KURA	Kura Oncology, Inc.	1,690	-0.46	-0.41	-0.42	Kura Oncology EPS misses by $0.04 [5/6/2021 4:46 PM]	26.15	1.15 (4.60%)	26.15	0.0 (0.00%)	13.86 - 43.00	505,501	490,000	10,629
Kura Oncology EPS misses by $0.04 [5/6/2021 4:46 PM] Kura Oncology, Inc. to Host Earnings Call [May-06-21 02:45PM] Kura Oncology Reports First Quarter 2021 Financial Results [May-06-21 04:04PM] Kura Oncology, Inc. (KURA) Q1 2021 Earnings Call Transcript [May-07-21 02:00PM]
24-02-2021	PM	7:30 AM ET (Feb 24)	KURA	Kura Oncology, Inc.	2,180	-0.45	-0.45	-0.39	Kura Oncology EPS in-line [2/24/2021 7:24 AM]	29.11	-4.21 (-12.64%)	34.50	1.18 (3.54%)	6.35 - 43.00	2,925,435	517,843	17,760
Kura Oncology EPS in-line [2/24/2021 7:24 AM] Kura climbs on FDA breakthrough therapy status for tipifarnib in head and neck carcinoma [2/24/2021 7:27 AM]
05-11-2020	PM	Before the open (Nov 5)	KURA	Kura Oncology, Inc.	1,880	-0.42	-0.39	-0.36	Kura Oncology EPS misses by $0.03 [11/5/2020 7:48 AM]	34.92	2.16 (6.59%)	32.76	0.0 (0.00%)	6.35 - 37.50	1,471,034	712,735	120,089

06-08-2020	AH	4:05 PM ET (Aug 6)	KURA	Kura Oncology, Inc.	946.42	-0.40	-0.41	-0.38	Kura Oncology EPS beats by $0.02 [8/6/2020 4:31 PM]	20.93	2.99 (16.67%)	18.00	0.06 (0.33%)	6.35 - 21.10	1,060,138	404,662	7,320